Fluconazole versus ketoconazole in the treatment of dermatophytoses and cutaneous candidiasis.
Stengel
F
F
Dermatology Division, CEMIC--University of Buenos Aires Medical School, Argentina.
Robles-Soto
M
M
Galimberti
R
R
Suchil
P
P
D000328:Adult; D002175:Candida / Q000302:isolation & purification; D002179:Candidiasis, Cutaneous / Q000188:drug therapy* / Q000382:microbiology; D004311:Double-Blind Method; D005260:Female; D015725:Fluconazole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007654:Ketoconazole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D010919:Placebos; D012008:Recurrence; D012074:Remission Induction; D015163:Superinfection / Q000175:diagnosis; D014005:Tinea / Q000188:drug therapy* / Q000382:microbiology; D014008:Tinea Pedis / Q000188:drug therapy* / Q000382:microbiology; D014249:Trichophyton / Q000302:isolation & purification
D010919:Placebos; D015725:Fluconazole; D007654:Ketoconazole